Palmer JL, Beaudet A, White J, Plun-Favreau J, Advances in Therapy 2010; 27(11): 814-27.
. Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China.Swiss Medical Weekly 2010; 140: w13103.
, , Goodall G, Brändle M. Evaluating the cost-effectiveness of self-monitoring of blood glucose in type 2 diabetes patients on oral anti-diabetic agents: A long-term modelling study in Switzerland.Diabetic Medicine 2010; 27(2): 189-96.
, Curtis BH, Boye KS, Goodall G, Pillemer SR. Anti-CD3 monoclonal antibody treatment in newly diagnosed type 1 diabetes patients: a hypothetical modelling analysis.Current Medical Research and Opinion 2010; 26(6): 1399-412.
, , Plun-Favreau J, White J. Systematic review of the cost-effectiveness of biphasic insulin aspart 30 in type 2 diabetes.